Form 4: Eli Lilly Director Acquires Stock Units

Sentiment:

Statement of Changes in Beneficial Ownership


Eli Lilly Director Ralph Alvarez acquired stock units valued at $1,129.35 as part of a deferred compensation plan.

Summary

  • Ralph Alvarez, a Director at Eli Lilly & Co. (LLY), acquired 10.9945 shares of common stock on June 15, 2026.
  • These shares were acquired as stock units under the Lilly Directors' Deferral Plan, in lieu of cash compensation.
  • The acquired units have a value of $1,129.35 and will be settled in shares of common stock upon Mr. Alvarez's separation from service.
  • Following this transaction, Mr. Alvarez beneficially owns 55,723.4672 shares of common stock, with 758 shares held indirectly through a trust.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine transaction related to director compensation and does not indicate new strategic initiatives or significant financial performance changes.

Positives

  • Director Ralph Alvarez has increased his beneficial ownership in Eli Lilly & Co. through the acquisition of stock units.
  • The acquisition is part of a structured deferred compensation plan, indicating a commitment to long-term incentive alignment for directors.

Risks

  • The acquired shares are subject to deferral and will be settled upon separation from service, meaning immediate liquidity is not available.
  • The value of the deferred stock units is tied to the future stock price of Eli Lilly & Co., exposing the director to market fluctuations.

Future Outlook

The acquired stock units will be settled in shares of common stock following the reporting person's separation from service.

Industry Context

StockSavvy.ai notes that director stock unit acquisitions are common in the pharmaceutical industry as a method to align executive and director interests with long-term shareholder value, particularly for companies like Eli Lilly that are heavily invested in R&D and subject to long product development cycles.

Stakeholder Impact

  • Shareholders: The transaction reflects a standard compensation practice for directors, with no immediate dilution or significant impact on share count. Long-term alignment of director interests with shareholders is maintained.
  • Directors: Ralph Alvarez's compensation is partially deferred, linking his future financial outcome to the company's stock performance.
  • Employees: No direct impact on employees is indicated by this filing.

Next Steps

  • Settlement of acquired stock units in shares of common stock upon reporting person's separation from service.

Key Dates

DateDescription
06/15/2026Transaction date for the acquisition of stock units.
06/16/2026Date of signature for the filing.

Keywords

Eli Lilly, LLY, Form 4, Director, Stock Units, Deferred Compensation, Beneficial Ownership, Securities Exchange Act

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.